Difference Between Emgality and Aimovig

With the time passed, the pharmaceutical sector has increased its production, and new researchers on different medicines and drugs for diseases minor to major have been developed.

/10

Health Quiz

Test your knowledge about topics related to health

1 / 10

What are the 5 food groups in a balanced diet?

Fruits, vegetables, grains, proteins, dairy

Fruits, vegetables, meat, dairy, sweets

Fruits, vegetables, carbohydrates, proteins, dairy

Fruits, vegetables, carbohydrates, meat, dairy

2 / 10

What is the best way to lower your risk of getting cancer?

Not smoking

Eating healthy

Exercising regularly

All of the above

3 / 10

What is the best way to prevent the spread of germs?

Coughing into your hand

Coughing into your sleeve

Using hand sanitizer frequently

Not covering your mouth when you cough

4 / 10

Food that contains sugar and starch. Most of your energy comes from this kind of food. Foods with natural sugar or starch in them are the best source of this kind of food.

Starches

Carbohydrates

Vitamins

5 / 10

What is the main cause of hypertension (high blood pressure)?

Genetics

Poor diet and lifestyle habits

Chronic stress

All of the above

6 / 10

Many children with asthma experience more severe reactions when they breathe ___________________.

Secondhand smoke

Carbon dioxide

Oxygen

Air

7 / 10

Which of the following is NOT a symptom of the common cold?

Sore throat

Runny nose

Diarrhea

Cough

8 / 10

What is the most common cause of a headache?

Dehydration

Stress

Lack of Sleep

Hunger

9 / 10

A thick, oily, dark, liquid that forms when tobacco burns is ___________.

Tar

Nicotine

Carbon

Coal

10 / 10

How many chambers are in the heart?

Your score is

Emgality vs Aimovig

The difference between Emgality and Aimovig is that the key ingredient or drug used to prepare the medicine Emgality is gulcanezumab which is a monoclonal antibody, whereas comparatively, on the other hand, the key ingredient or the drug used to prepare the medicine Aimovig is erenumab which is also a monoclonal antibody. Monoclonal antibodies are the antibodies of the immune system that are prepared in the lab by cloning certain white blood cells.

Want to save this article for later? Click the heart in the bottom right corner to save to your own articles box!

The medicine is used as the preventive measure for the treatment of migration pain as well as the episodic cluster of headaches in adults. The main ingredient of the drug used to make it is galcanezumab.

Aimovig is a medicine which is approved by FDA on 17 May 2018. The medicine is available in the market by its brand name, and there is no generic medicine available for the same.

Comparison Table

Parameters of Comparison	Emgality	Aimovig
Approval for Migration Prevention	27 September 2018	17 May 2018
Drug Ingredient	Galcanezumab-gnlm	Erenumab-aooe
Process of intake	It is given in subcutaneous layer self-injection, prefilled pen, or syringe.	Given on the subcutaneous layer self-injection by prefilled autoinjector.
Working	The drug binds to the CGRP which prevents its effect	The drug blocks the CGRP receptor.
Half Life	27 days	28 days
Used For	Treatment of migraine and the episodic cluster of headache in adults	Treatment of migraine in adults
Dosage	In starting 240mg then 120mg for migraine while 300mg (3×100mg) injection monthly for the episodic cluster of headache.	70mg monthly, while sometimes the dose can be doubled depending on the patient.

What is Emgality?

Emgality is a medicine developed by Eli Lily and Company. The medicine got his approval for treating migration pain on 27 September 2018 while for treating episodic cluster of headache on 04 June 2019.

The medicine is injected into the subcutaneous layer of the skin with the help of prefilled pen or syringe. The dosage composition given to the patient for treating migraine is about 240 mg, but later it can be reduced to 120 mg.

Some of the side effects reported by the patients after using the medicine are – constipation, itchy skin, dizziness, welts, injection site reactions around 18%, anti-drug antibodies (up to 12.5%).

What is Aimovig?

Aimovig is a medicine developed by Amgen. The medicine Aimovig got his approval from FDA for treating patients (adults) with migraines on 17 May 2018.

The dosage composition given to the patient for treating its migraine pain is about 70 mg, while it can be doubled depending upon the need of the patient.

Some of the side effects reported by the patients after using the medicine are – constipation, itchy skin, tiredness, cramps, muscle spasms, injection site reactions of about 6%.

Main Differences Between Emgality and Aimovig

The medicine emgality is used for the treatment of migraine and the episodic cluster of headache in adults, while aimovig is only used for the treatment of migration pain in adults.
The dosage of the emgality is given in initial days is 240 mg which is then lowered to 120 mg later for treating migration pain, but the dosage given for the treatment of episodic cluster of headache is 300mg (3 × 100mg) injection while on the other hand, the dosage of the aimovig given to the patient initially is 70 mg once in a month, but sometimes the dose of the medicine can be doubled depending upon the patient.

References

One request?

I’ve put so much effort writing this blog post to provide value to you. It’ll be very helpful for me, if you consider sharing it on social media or with your friends/family. SHARING IS ♥️

Facebook Tweet Pin Print Email

Sandeep Bhandari

Sandeep Bhandari holds a Bachelor of Engineering in Computers from Thapar University (2006). He has 20 years of experience in the technology field. He has a keen interest in various technical fields, including database systems, computer networks, and programming. You can read more about him on his bio page.